Overview
Zuragen™ Injection
ZuraPrep™
Centros™
Pipeline |
Ash Access
Technology, Inc is committed to building a comprehensive product
portfolio of specialty therapeutics and medical devices that will
advance the care of patients requiring vascular access and infection control in the acute
and chronic health care enviornments.
Currently there are six candidates in our product pipeline that
are undergoing investigation.
| Estimated Developmental Status as of
Q3 2008 |
Product
Formulation |
Pre-clinical
FDA
Approved Safety Study |
Pivotal
PMA Trial
(AZEPTIC) |
|
Zuragen™
 |
| Estimated Developmental Status as of
Q3 2008 |
Product
Formulation |
Human Pilot
Efficacy and Safety Studies |
Pre-IND
Submission and Meeting |
|
ZuraPrep™
|
Catheter
Portfolio |
Catheter
Type |
Prototype
Development |
Bench/ Clinical
Testing |
FDA 510(k)
Status |
Centros™ |
LT*
Tunneled Hemodialysis |
Completed |
Completed |
Approved
June 2008 |
SureFlow™ |
LT
Tunneled Hemodialysis |
Completed |
Ongoing |
TBD |
MaxFlow™ |
Peritoneal
Dialysis |
Completed |
Ongoing |
TBD |
BaxCath™
Impregnation System |
All
Ash Catheters |
Ongoing |
Ongoing |
TBD |
*LT = long-term
|
